Comparison of 3.0 T PAC versus 1.5 T ERC MRI in Detecting Local Prostate Carcinoma.
Xin Ye, Udochukwu yoyo, Albert Lu, Jed Dixon, Heather Rojas, Samuel Randolph, Thomas Kelly
Abstract
Increased utilization of prostate-specific antigen screening and prostate imaging has led to detection of smaller indolent tumors that traditional brachytherapy and prostectomy may be too aggressive for. New targeted techniques require greater locational accuracy of tumor detection to guide treatment. Prostate MRIs can be important for initial staging and for guiding targeted biopsies and treatments. We compared the accuracy of local staging of prostate cancer using 1.5 Tesla MRI with endorectal coil (ERC) versus 3 Tesla MRI with pelvic array coil (PAC) to the gold standard of trans-rectal US guided biopsies (TRUS). ERC is uncomfortable and has many imaging artifacts that may limit detection, so we hypothesize that 3 T MRI with PAC will have improved performance. 72 patients underwent prostate MRIs and TRUS prostate biopsies from 2008-2011 (33 were excluded due to prior radiation therapy, 24 patients underwent 1.5 T ERC and 15 underwent 3.0 T PAC.) 3.0 T PAC was trending towards greater sensitivity although we lack the statistical power for significance.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Use of Bioelectric Impedance Analysis (BIA) as a new method to detect prostate cancer
R. Bartoletti, A. Greco, … G. Valenza·bioRxiv·Feb 12, 2020
- In-bore MRI-compatible Transrectal Ultrasound and Photoacoustic Imaging
R. Murakami, Y. Wang, … H. K. Zhang·bioRxiv·Nov 27, 2023
- Measurement of Prostate Volume with MRI (A Guide for the Perplexed): Biproximate Method with Analysis of Precision and Accuracy
N. F. Wasserman, E. Niendorf, B. Spilseth·bioRxiv·Dec 4, 2019
- Novel Magnetic Resonance Imaging strategy targeting Neurotensin Receptors in detection of Prostate Cancer
Mitul Desai, Neville N.C. Tam, … Jean. King·bioRxiv·Aug 24, 2017
- Nanoparticles targeted to fibroblast activation protein outperform PSMA for MRI delineation of primary prostate tumours
N. Dmochowska, V. Milanova, … B. Thierry·bioRxiv·Jun 10, 2022
- Stratifying risk of prostate cancer recurrence following external beam radiation therapy: Comparing prostate MRI with prostate biopsy pathology.
William Millard, Jason Slater, … David Bush·bioRxiv·Jun 3, 2016